BMS Just Paid to Solve Its Patent Cliff With Someone Else’s Pipeline
Bristol Myers Squibb's 13-program deal with Hengrui Pharma is the clearest signal yet that Western pharma's next growth decade...
China pharma expansion
Bristol Myers Squibb's 13-program deal with Hengrui Pharma is the clearest signal yet that Western pharma's next growth decade...